- Home
- CPHI vs TOVX Comparison
CPHI vs TOVX Comparison
Compare CPHI & TOVX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CPHI
- TOVX
- Stock Information
- Founded
- CPHI N/A
- TOVX 2001
- Country
- CPHI China
- TOVX United States
- Employees
- CPHI N/A
- TOVX N/A
- Industry
- CPHI Biotechnology: Pharmaceutical Preparations
- TOVX Biotechnology: Pharmaceutical Preparations
- Sector
- CPHI Health Care
- TOVX Health Care
- Exchange
- CPHI Nasdaq
- TOVX Nasdaq
- Market Cap
- CPHI 4.0M
- TOVX 4.7M
- IPO Year
- CPHI N/A
- TOVX 2006
- Fundamental
- Price
- CPHI $0.21
- TOVX $1.55
- Analyst Decision
- CPHI
- TOVX Strong Buy
- Analyst Count
- CPHI 0
- TOVX 1
- Target Price
- CPHI N/A
- TOVX $6.00
- AVG Volume (30 Days)
- CPHI 701.9K
- TOVX 136.3K
- Earning Date
- CPHI 03-31-2025
- TOVX 03-24-2025
- Dividend Yield
- CPHI N/A
- TOVX N/A
- EPS Growth
- CPHI N/A
- TOVX N/A
- EPS
- CPHI N/A
- TOVX N/A
- Revenue
- CPHI $5,544,620.00
- TOVX N/A
- Revenue This Year
- CPHI N/A
- TOVX N/A
- Revenue Next Year
- CPHI N/A
- TOVX N/A
- P/E Ratio
- CPHI N/A
- TOVX N/A
- Revenue Growth
- CPHI N/A
- TOVX N/A
- 52 Week Low
- CPHI $0.13
- TOVX $1.14
- 52 Week High
- CPHI $0.50
- TOVX $17.00
- Technical
- Relative Strength Index (RSI)
- CPHI 48.21
- TOVX 52.70
- Support Level
- CPHI $0.19
- TOVX $1.54
- Resistance Level
- CPHI $0.24
- TOVX $1.75
- Average True Range (ATR)
- CPHI 0.02
- TOVX 0.13
- MACD
- CPHI 0.00
- TOVX 0.02
- Stochastic Oscillator
- CPHI 46.67
- TOVX 66.67
About CPHI China Pharma Holdings Inc.
China Pharma Holding Inc is a drug manufacturing company. It is mainly engaged in the development, manufacture, and marketing of pharmaceutical products for human use in connection with a variety of high-incidence and high-mortality diseases and medical conditions prevalent in the People's Republic of China. The company mainly manufactures pharmaceutical products in the form of dry powder injectables, liquid injectables, tablets, capsules, and cephalosporin oral solutions. The product line of the company includes cefaclor dispersible tablets, clarithromycin granules, roxithromycin dispersible tablets, andrographolide tablets, ozagrel sodium for injection, gastrodin injection and others.
About TOVX Theriva Biologics Inc.
Theriva Biologics Inc is a clinical-stage pharmaceutical company developing a novel oncolytic adenovirus (OV) platform to address devastating cancers with high unmet needs. It is a lead clinical-stage program VCN-01, designed to break down the tumor stroma, and its preclinical-stage program VCN-11 leverages its proprietary Albumin Shield Technology to protect systemically administered oncolytic viruses from the host immune system.